According to the tumours’ location, KRAS mutations were equally distributed within the locations, with 33.3% of cases identified in the right colon, 33.3% of cases in the left colon, and 33.3% of cases in the rectum, while no mutations have been identified in the transverse colon tumours. Here, KRAS is linked to neoplasm.